CMV-Specific CD19-CAR T-cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CMV-Specific CD19-CAR T-cells, covering 2026-02-23 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma [Phase 1]